326 related articles for article (PubMed ID: 15605761)
41. Targeted antiestrogens.
Tonetti DA; Jordan VC
Prog Clin Biol Res; 1997; 396():245-55. PubMed ID: 9108602
[No Abstract] [Full Text] [Related]
42. Tamoxifen in early breast cancer.
Benson JR
Lancet; 1998 Aug; 352(9125):404-5. PubMed ID: 9717955
[No Abstract] [Full Text] [Related]
43. Reliability of estrogen receptors in predicting hormonal responsiveness in treatment of metastatic breast cancer.
Valenstein SL; Voigt W; Vogel CL; Thomsen S; Temple W
J Fla Med Assoc; 1979 Nov; 66(11):1144-8. PubMed ID: 501325
[No Abstract] [Full Text] [Related]
44. Type of estrogen receptor determines response to antiestrogen therapy.
Villa E; Dugani A; Fantoni E; Camellini L; Buttafoco P; Grottola A; Pompei G; De Santis M; Ferrari A; Manenti F
Cancer Res; 1996 Sep; 56(17):3883-5. PubMed ID: 8752151
[TBL] [Abstract][Full Text] [Related]
45. Tamoxifen, mammographic density, and breast cancer prevention.
Boyd NF
J Natl Cancer Inst; 2011 May; 103(9):704-5. PubMed ID: 21487099
[No Abstract] [Full Text] [Related]
46. With maturity comes confidence: EBCTCG tamoxifen update.
Chia SK; Wolff AC
Lancet; 2011 Aug; 378(9793):747-9. PubMed ID: 21802719
[No Abstract] [Full Text] [Related]
47. [Prediction for efficacy of endocrine therapy for breast cancers using gene profiling].
Iwase H; Yamamoto Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():549-54. PubMed ID: 17682209
[No Abstract] [Full Text] [Related]
48. Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review.
Jameera Begam A; Jubie S; Nanjan MJ
Bioorg Chem; 2017 Apr; 71():257-274. PubMed ID: 28274582
[TBL] [Abstract][Full Text] [Related]
49. Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
Cappelletti V; Veneroni S; Coradini D; Oriana S; Tomasic G; Younes M; Daidone MG
J Natl Cancer Inst; 2003 Apr; 95(8):629-30. PubMed ID: 12697859
[No Abstract] [Full Text] [Related]
50. Drug interaction with estrogen receptors for the control of breast neoplasia (review).
Leclercq G; Heuson JC
Anticancer Res; 1981; 1(4):217-28. PubMed ID: 7049050
[No Abstract] [Full Text] [Related]
51. [Hormonal dependence and hormonal therapy of cancers of the endometrium and breast].
Barrat J
Rev Fr Gynecol Obstet; 1985 Jul; 80(7):549-53. PubMed ID: 4035192
[TBL] [Abstract][Full Text] [Related]
52. Estrogen and progesterone receptors in human breast cancer.
Seckinger D
J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
[No Abstract] [Full Text] [Related]
53. The regulation of estrogen receptor expression and function in human breast cancer.
Ferguson AT; Lapidus RG; Davidson NE
Cancer Treat Res; 1998; 94():255-78. PubMed ID: 9587692
[No Abstract] [Full Text] [Related]
54. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
Hagen ML; Hellmers M; Abrahamsen B; Hagen C
Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
[No Abstract] [Full Text] [Related]
55. Endocrine treatment of breast cancer.
Fahey TJ
Curr Ther Endocrinol Metab; 1997; 6():593-8. PubMed ID: 9174813
[No Abstract] [Full Text] [Related]
56. [Does anti-estrogen therapy after estrogen receptor analysis have value in palliative therapy of hepatocellular carcinoma?].
Kreysel C; Porschen R
Z Gastroenterol; 1998 Jul; 36(7):605-7. PubMed ID: 9738309
[No Abstract] [Full Text] [Related]
57. [Nuclear receptors--watchful mistrust of tamoxifen].
Dingermann T; Zündorf I
Pharm Unserer Zeit; 2004; 33(5):350-1. PubMed ID: 15497327
[No Abstract] [Full Text] [Related]
58. New antiestrogen shows promise in ER-positive breast cancers.
Oncology (Williston Park); 1994 Aug; 8(8):58. PubMed ID: 7947003
[No Abstract] [Full Text] [Related]
59. Are estrogen receptor content in breast cancer and effects of tamoxifen on sex hormone-binding globulin markers for individual estrogen sensitivity?
Löfgren L; von Schoultz E; Fernstad R; von Schoultz B; Carlström K
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):76-9. PubMed ID: 16621526
[TBL] [Abstract][Full Text] [Related]
60. Endocrine treatment and prevention of breast and gynaecological cancers.
Neven P; Vergote I; Van Ginderachter J; van Dam P; Tjalma W; De Rop C; De Prins F
Eur J Cancer; 2002 Nov; 38 Suppl 6():S1-11. PubMed ID: 12409056
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
